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ABSTRACT

Acylation of Superoxide Dismutase 1 (SOD1) at K122 Alters SOD1 Localization and
SOD1-Mediated Inhibition of Mitochondrial Respiration
Nathan William Rodriguez
Department of Chemistry and Biochemistry, BYU
Master of Science
Cu/Zn Superoxide Dismutase (SOD1), is a ubiquitous antioxidant enzyme with several emerging
roles outside of its canonical function. SOD1 is also emerging in central roles in cancer and
neurodegenerative pathologies. Little is known about SOD1 regulation, particularly at a posttranslational level. Post-translational modifications (PTMs) play an important role in enabling
proteins to rapidly respond to their environment. Therefore, identifying specific PTMs involved
in protein regulation represents a powerful opportunity to interfere with any associated
pathologies.
This work employs proteomics to identify mechanisms of post-translation regulation on cell
survival signaling proteins. We focused on SOD1, which protects cells from oxidative stress. We
found that acylation of K122 on SOD1, while not impacting SOD1 catalytic activity, suppressed
the ability of SOD1 to inhibit mitochondrial metabolism at respiratory complex I. We found that
deacylase depletion increased K122 acylation on SOD1, which blocked suppression of
respiration in a K122-dependent manner. In addition, we found that acyl-mimicking mutations at
K122 decreased SOD1 accumulation in mitochondria, initially hinting that SOD1 may inhibit
respiration directly within the intermembrane space (IMS). However, surprisingly, we found that
forcing the K122 acyl mutants into the mitochondria with an IMS-targeting tag did not recover
their ability to suppress respiration. Moreover, we found that suppressing or boosting respiration
levels toggled SOD1 in or out of the mitochondria, respectively. These findings place SOD1mediated inhibition of respiration upstream of its mitochondrial localization. Interestingly, we
also found that K122 acyl mutants were sufficient to prevent mitochondrial accumulation of the
G93A SOD1 clinical mutant. We observed increased autophagic activity in G93A expressing
cells compared to WT or G93A/K122-acyl mimic double mutants, and found that this double
mutant was just as prone to aggregate as G93A SOD1—suggesting that SOD1 aggregation is
more toxic when in the mitochondria. We observed increased protein turnover rates in cells
expressing SOD1 G93A, in support of increased autophagy. Lastly, deletion-rescue experiments
show that a respiration-defective mutant of SOD1 is also impaired in its ability to rescue cells
from toxicity caused by SOD1 deletion. Together, these data suggest a new interplay between
SOD1 acylation, metabolic regulation, SOD1 aggregate toxicity, and SOD1-mediated cell
survival.
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CHAPTER 1: INTRODUCTION TO SOD1 AND DISEASE
Enzymatic and other functions
Superoxide dismutase 1 (SOD1) is a copper/zinc based metalloprotein whose best
characterized function is to scavenge superoxide anion (O2-), a type of reactive oxygen species
(ROS), and break it down into hydrogen peroxide (H2O2) and molecular oxygen (O2). This
antioxidant role for SOD1 is important for cell maintenance, both in terms of health and
signaling. At high concentrations, ROS can cause oxidative stress, initiate radical chemistry, and
react with DNA, lipids, and proteins (1, 2). Genomic instability caused by oxidative damage
contributes to several pathologies, including carcinogenesis, ageing, diabetes, as well as
neurological and cardiovascular diseases (2-4). Despite being toxic at high concentrations, at
lower to intermediate levels, ROS in general act as a kind of byproduct signaling molecule. For
example, as reviewed by Finkel, ROS can regulate growth factor response, and also assist with
inflammatory response initiation (5). Therefore, by moderating ROS levels, SOD1 not only
abates oxidative stress and cellular damage, but also plays an indirect role in cellular signaling
pathways.
The idea of SOD1 as a signaling protein, however, is not novel. Interestingly, although
SOD1 is primarily thought of as an antioxidant, in yeast ~1% of SOD1 expressed in cells is
sufficient to maintain ROS below cytotoxic levels (6). And given that it is known to localize
primarily to the cytosol, but also to the nucleus as well as mitochondria, it is easy to imagine
that, in addition to ROS scavenging, SOD1 may have additional functions. For example, Tsang
et al. as well as Wood and Thiele have described SOD1 as exerting transcription-regulatory
function within the nucleus (7, 8). It has also been shown that SOD1 plays an active role in
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copper and zinc buffering (9, 10). Furthermore, another group has proposed that SOD1 may
compete with cytochrome c oxidase (CcO) for copper from a common pool within the
mitochondrial intermembrane space (11, 12), and therefore SOD1 would indirectly regulate
mitochondrial respiration by limiting CcO function in the electron transport chain. Beyond these
findings, Reddi and Culotta showed that SOD1 in yeast is important for directly regulating
mitochondrial respiration through binding interactions with Wnt signaling proteins (13).
Specifically, they showed SOD1 suppresses respiration by binding and stabilizing two casein
kinase 1-gamma homologs. Together, these studies strongly suggest a multifaceted role for
SOD1 in the cell.
Dysregulation, disease, and autophagy
SOD1 mutations are strongly implicated in the neurodegenerative disease
amyotrophic lateral sclerosis (ALS). Specifically, 5–10% of all ALS cases are familial, and
SOD1 mutations account for about 20–25% of all familial cases (14-17). There are at least 160
identified SOD1 mutations known to cause ALS (18). The precise mechanisms underlying how
these mutations lead to ALS are unclear and heavily debated. In most cases, however, it is
accepted that these mutations induce SOD1 to misfold and aggregate, and that these aggregates
cause downstream pathological effects (18). Observed phenotypes include mitochondrial
metabolism deficiencies, axonal failure, overwhelming of the proteasome, and endoplasmic
reticulum stress (18), the outcome of which is often motor neuron cell death.
Extensive work has been done to characterize how SOD1 mutations lead to aggregation
and why those aggregates are toxic. Münch and Bertolotti found that many SOD1 mutations may
expose or create additional hydrophobic surface area (19). Elam et al. found that SOD1
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mutations sometimes interfere with copper and/or zinc loading into SOD1 (20), and Tiwari et al.
found that metal-deficient SOD1 is prone to expose hydrophobic faces (21). These hydrophobic
faces then favor direct intermolecular interactions with the same face of other mutant SOD1
proteins. Additionally, in 2011, it was shown that these same hydrophobic faces function as
nucleation sites for aggregates on the surfaces of lipid membranes (22). Interestingly, Brian
Shaw’s group found that aspirin-induced hyperacetylation of mutant, aggregate-prone SOD1
increased its net negative surface charge and significantly reduced aggregation, suggesting that
net charge may contribute to SOD1’s propensity to aggregate (23).
Whatever the mechanism for aggregation, it is clear that SOD1 aggregates play a
principle role in mutant SOD1’s toxic gain-of-function, although how and why remains
unsolved. Many groups agree that the proteotoxic stress caused by overwhelming quantities of
SOD1 aggregates lead to mutant SOD1’s neurodegenerative effects. Particularly, Pickles et al.
posit that aggregation of misfolded SOD1 within the mitochondria is damaging and eventually
detrimental to neurons (24). As one possible explanation for the proteotoxicity, Zhang et al.
showed that SOD1 aggregation in ALS mice leads to a stalled cell recycling process known as
autophagy (25), which will be further discussed in chapter 3.
SOD1 is also reportedly overexpressed in several cancers, including lung
adenocarcinoma (26), non-small-cell lung cancer (27), and 70% of primary breast cancers (28).
Cancer cells often experience ischemia and must adapt to a hypoxic, low-glucose environment,
which results over time in higher ROS concentrations (29, 30). In the context of cancer,
increased SOD1 may benefit cells by neutralizing excess ROS and thereby increasing their rate
of survival. Interestingly, it may also be possible that SOD1’s respiration-suppressing capacity
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further enable cell survival by promoting alternate metabolic pathways, such as the Warburg
Effect, which is characterized by reduced mitochondrial respiration.
These functions of SOD1 suggest a complex mode of pathogenicity and more
importantly, regulation. Yet how SOD1 is regulated remains unknown, particularly on a post
translational level. Elucidating these regulatory mechanisms could allow for manipulation of
SOD1 prior to or during disease progression.
SOD1 Regulation
In 2009, proteomics work done by Choudhary, et al. identified K122 of SOD1 as an
acetylation target (31). K122 is an amino acid residue that lies within a highly conserved and
functionally critical domain of SOD1 known as the electrostatic loop. The amino acid residues in
this loop help direct superoxide anions to the active site of SOD1 (32). One of these residues is a
histidine responsible for binding copper, which is necessary for SOD1 to scavenge ROS (33).
Previous studies show that some mutations within this loop, or of residues that stabilize this loop,
compromise SOD1 activity (34). This evidence indicates the importance of residues within the
electrostatic loop region, including K122.
In 2011, Andersen, et al. identified the same SOD1 K122 as an acetylation target in the
context of tumor like oxidative stress (35), suggesting that this acyl modification may alter
SOD1 function in response to glucose and oxygen limited conditions. In 2013, Park, et al.
identified this same residue as a target for succinylation in response to knock out of SIRT5, a
well characterized desuccinylase (36). Later that year, Lin, et al. correlated this post translational
modification (PTM) with reduced antioxidant activity (37). These PTMs occurred naturally, and
in response to different physiological conditions, strongly suggesting that SOD1 may exhibit a
4

post-translational mode of regulation, possibly at K122. Based on these findings and work in our
lab, we hypothesized that acetylation and succinylation (acylation) of SOD1 K122 modulate
SOD1 antioxidant and respiratory function to help cells adapt to adverse conditions and nutrient
stress.
Here, we study the previous findings on K122 acetylation and succinylation, and take
them further by putting them in context of SOD1 regulation. We examine the effect of SOD1
K122 acylation on catalytic activity, and its role in mitochondrial metabolism and respiration.
We validate the role of SIRT5 in governing SOD1 K122 desuccinylation and look at the effects
of SIRT5 depletion on SOD1-mediated suppression of respiration. We also examine the
relationship between mitochondrial respiration, SOD1 K122 acylation, and SOD1 localization
and where SOD1 exerts its regulatory effect on respiration. Our findings offer novel
understanding of SOD1’s mode of regulation as well as valuable insight into SOD1’s role in
promoting cell growth and survival. Our data suggest a feed-forward loop wherein SIRT5
deacylates K122, after which SOD1 represses mitochondrial respiration, leading to SOD1
mitochondrial localization. We postulate that this mechanism may provide pro-survival benefits
to cells. Further work is needed to determine if these acylations interfere with interactions
between SOD1 and known regulators of respiration.
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CHAPTER 2: ACYLATION OF SUPEROXIDE DISMUTASE 1 (SOD1) AT K122 GOVERNS
SOD1-MEDIATED INHIBITION OF MITOCHONDRIAL RESPIRATION
INTRODUCTION
The regulation of cell signaling events through protein post-translational modifications
(PTMs), including phosphorylation, acylation, glycosylation and ubiquitination, provides a means
for cells to respond rapidly to environmental cues. Defects in the pathways that control PTMs
underlie many human diseases and typically represent a fundamental breakdown in
communication between the cell and its environment. Mass spectrometry-based approaches have
dramatically expanded our view of PTMs, both in terms of PTM variety and proteome coverage.
Over 200 different PTMs have been described (uniprot.org) and many, including phosphorylation
and ubiquitination, regulate essentially every known biological process in the cell. With this
understanding of PTM breadth, the challenge is to now ‘zoom in’ to understand the functional
consequences of specific PTMs. Thus, our goal is to understand how PTMs affect protein function,
with particular focus on cell survival signaling nodes and pathways.
Here we used an affinity purification approach, coupled with liquid chromatography
tandem mass spectrometry (LC-MS/MS), to identify PTMs in primary untreated mouse tissues.
Using a recently developed PTM analysis tool (SAPH-ire) to prioritize our functional studies, we
evaluated PTMs from our experiment against all other experimentally observed PTMs curated for
the Cu/Zn Superoxide Dismutase (SOD) domain family (38, 39). This analysis highlighted an acylmodified lysine on SOD1, which we focused on in this study. SOD1 is a well conserved
metalloenzyme best known for its catalytic role in disproportionation of superoxide radicals (O2-)
into molecular oxygen (O2) and hydrogen peroxide (H2O2) (9, 40-47). Its expression is primarily
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cytosolic, although a fraction of SOD1 exists in the mitochondrial intermembrane space (IMS).
Studies spanning multiple model organisms and cell lines have underscored the importance of
SOD1 in oxidative stress protection (reviewed in (48, 49)). Accordingly, SOD1 is overexpressed
in a variety of cancers and SOD1 deletion in mice results in a higher incidence of liver cancer (43).
Additionally, mutations in SOD1 that increase its propensity to aggregate cause toxicity in motor
neurons, resulting in a familial form of amyotrophic lateral sclerosis (ALS) (reviewed in (49)).
Several lines of evidence suggest that SOD1 biology may be more complex than initially
thought. While SOD1 deletion is toxic in cultured cells due to an accumulation of oxidative
damage (50, 51), titration of SOD1 expression against a SOD1 null background in yeast revealed
that only a small fraction, representing about 1% of total SOD1, is required for protection against
oxidative stress (6). This suggests that SOD1 may have additional functions beyond its traditional
role in reactive oxygen species (ROS) scavenging. Indeed, studies suggest that SOD1 has roles in
zinc and copper buffering (9, 10) and in regulating gene transcription (7, 8). In addition, a recent
study by Reddi and Culotta found that yeast SOD1 suppressed mitochondrial respiration (13).
However, despite this emerging complexity in SOD1 biology and clear roles for SOD1 in human
disease, we have a limited understanding of SOD1 regulation at a post-translational level.
Here we uncover a novel regulatory mechanism by which a Sirtuin-governed acylation
within the electrostatic loop of SOD1, at K122, suppresses SOD1-mediated inhibition of
mitochondrial metabolism in mammalian cells. This observation provided genetic tools to help
understand the relationship between SOD1 mitochondrial localization and metabolic regulation as
well as the potential contribution of this SOD1 metabolic function to its role in promoting cell
survival. Our data suggest a model in which Sirtuin-mediated deacylation of SOD1 promotes its
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inhibition of respiration, which in turn, elevates levels of mitochondrial SOD1 and contributes to
SOD1’s pro-survival function.
RESULTS
With the goal of identifying PTMs on cell survival signaling nodes, we used, as a starting
point, several PTM-specific antibody resins to compare in vivo PTMs across multiple mouse
tissues (brain, liver, and embryo homogenates). The experimental layout is shown in Figure 1A
and included several phospho-motif, ubiquitin and acetyl-lysine affinity resins. A complete set of
database search results from this experiment are publicly available as a Scaffold file (Proteome
Software Inc.) at https://discovery.genome.duke.edu/express/resources/3023/3023_PTMScanAll_
withTiO2.sf3. In an effort to zoom in on PTMs on cell survival signaling nodes, we applied gene
ontology analysis, as well as manual sorting by protein function. Two proteins of interest, 14-3-3ζ
and SOD1, are shown in Figure 1B. 14-3-3ζ is a phospho-serine/threonine binding protein that is
overexpressed in a variety of cancers and promotes cell survival by directly modulating a network
of phospho-proteins. In combining our PTM data sets, we identified PTMs on 14-3-3ζ of unknown
function, including phospho-Y149, Ub-K139, in addition to well-described PTMs, such as AcK49 (31, 35, 52). In particular, acetylation of K49 is known to disrupt 14-3-3ζ interactions and our
previous work identified HDAC6 as the K49-targeted KDAC (52).
SAPH-ire identifies PTMs with high function potential in the SOD domain family.
Our attention was also drawn to SOD1, which acts as one of the main modes of defense against
oxidative stress by catalyzing the disproportionation of superoxide radicals (O2-) to molecular
oxygen (O2) and hydrogen peroxide (H2O2). Figure 1B lower panel shows the crystal structure of
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Figure 1. Identification of PTMs on 14-3-3ζ and SOD1. (A) Brain, liver, and whole embryo mouse tissues were
homogenized and digested with trypsin. Peptides were subject to affinity purification by the indicated antibody resin.
Peptides were eluted and analyzed by LC/MS/MS. Proteomics data were analyzed with Scaffold software. (B) Crystal
structures of human 14-3-3ζ (PDB: 4IHL) and mouse SOD1 (PDB: 3GTT) with PTMs identified in the proteomics
data.

the SOD1 dimer and PTMs identified from our proteomics data. In an effort to prioritize PTMs on
SOD1, we utilized SAPH-ire FPx, a machine-learning-based PTM “hotspot” finder that examines
experimentally-identified PTMs and prioritizes the PTMs for likelihood of biological function
based on a number of parameters as previously described (38, 39, 53). Using human SOD1
(UniProt ID: P00441) as an anchor, PTMs were evaluated in the context of the entire eukaryotic
SOD domain family (InterPro ID: IPR001424). Interestingly, PTMs localized in the region
9

between S98 and K128 exhibited the highest SAPH-ire FPx scores across the entire domain
(Figure 2A). In fact, the top seven PTM sites with the highest FPx score were all within this region
(Figure 2B-D). We became interested in an acylated lysine (K122) that was found not only in our
mouse proteomics data set but was also identified by SAPH-ire in the region with the highest FPx
scores and was one of the top two highest ranking modified lysine hotspots in the SOD domain
family (Figure 2A-D). In comparing the two acyl-lysines (K122 and K128) within the top SAPHire cluster, K122 had the highest number (eight) of co-aligned PTMs in the family (indicated by
circle size) and also the second highest number (five) of independent MS-based observations
(indicated by circle color, Figure 2A-C), suggesting that K122 may be an important regulatory
site. K122 sits within the electrostatic loop (Figure 2E), which has nearby residues (H120 and
D124) important for binding zinc and copper (54). K122 is conserved from human to bird (Figure
2F), and has been identified in previous studies, among other acyl-lysines, as acetylated and
succinylated (31, 37, 55-57) (Figure 2G). A study by Lin et al. found that SIRT5 desuccinylates
K122 and it was proposed to affect SOD1 antioxidant activity (37). In addition, a recent study
using a site-specific antibody demonstrated that K122 is acetylated on endogenous SOD1 in
multiple cell types throughout the murine nervous system (58), although the impact of the acetyl
modification on SOD1 function was not demonstrated. With this background, we investigated the
functional impact of K122 acylation on SOD1.
Acyl-mimicking mutations at K122 have no effect on SOD1 dimerization or ROS
scavenging activity. To examine the effect of acylation at K122 on various SOD1 functions, we
generated acetyl-mimicking K122Q and succinyl-mimicking K122E mutations. Although there
are structural differences between glutamine/glutamate and Nε-acyl-lysine, these mutations mimic
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Figure 2. SAPH-ire identifies PTMs with high function potential in the SOD domain family. (A) Plot of SAPHire function potential score for 34 modified alignment positions (MAPs) along the length of the SOD domain family.
Domain family alignment position and corresponding native position of human SOD1 are plotted on the x-axis for
reference (from N- to C-terminal). The number of distinct PTMs observed within a MAP (PTM count; PTMc) is
represented by circle size. The number of independent literature sources documenting observation of PTMs in each
MAP (Mass Spec Source Count; MSSrc) is indicated by circle color. (B) Rank ordered plot of SAPH-ire function
potential scores for the 34 SOD domain family MAPs. Residue positions correspond to mouse SOD1 residues found
in each of the top 7 domain family MAPs. (C) Projection of the top 7 MAPs onto the crystal structure of mouse SOD1
(UniProt ID: P08228) (PDB: 3GTT, Chain A). (D) Table summarizing the identities and predominant PTMs observed
11

for each of the top 7 SOD MAPs. (E) Zoomed in crystal structure of the mouse SOD1 (PDB: 3GTT) electrostatic loop
featuring K122 (red) modified with an acetyl group (grey) and surrounding amino acids (blue). (F) Sequence
alignment of human, mouse, wolf, chicken, and yeast SOD1 with K122 highlighted in red. (G) Table indicating all
known lysine acetyl or succinyl modifications of human SOD1, known deacetyl/succinylases, and phenotype of the
modifications.

the change in charge associated with the acyl modifications. One limitation of this approach is that
the mutations abrogate any other lysine modification (e.g., ubiquitin) that may occur at the site,
thus comparison with the K-to-R control (mimics a non-acylated lysine, but also abrogates other
lysine PTMs) is critical. To determine whether the acyl-mimicking mutants could dimerize with
WT SOD1, we overexpressed Flag-tagged WT SOD1 together with either HA-tagged WT SOD1
or HA-tagged mutant SOD1 in HEK-293 cells and saw no difference in dimerization between WT
and acyl-mimicking SOD1 mutants (Figure 3A). We also saw no difference in the binding of these
SOD1 mutants to the copper chaperone for superoxide dismutase (CCS; Figure 3B), which
promotes the final stage of SOD1 folding and maturation. Furthermore, in contrast to the study by
Lin et al. (37), we found no difference in ROS scavenging between WT and the acyl-mimicking
SOD1 mutants. This was verified in multiple ROS scavenging assays with purified SOD1, a
nitrotetrazolium blue gel assay, and included the ROS scavenging-impaired SOD1 point mutant
G85R, as a positive control (Figures 3C and 3D).
K122 acyl-mimics inhibit SOD1-mediated control of mitochondrial respiration.
Although SOD1 is commonly thought of as an antioxidant, only 1% of SOD1 expressed in cells is
necessary to keep ROS below cytotoxic levels (6). The rationale for such high levels of SOD1 has
led others to propose that it may have important functions beyond disproportionation of oxygen
radicals (13). Previous studies have suggested SOD1 has roles in cellular zinc (10) and copper
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Figure 3. Acyl-mimic mutations at K122 of SOD1 do not affect canonical SOD1 ROS scavenging activity. (A)
HEK 293 cells were co-transfected with Flag-tagged WT SOD1and HA-tagged WT, K122R, K122E, or K122Q SOD1
expression plasmids. Flag-WT SOD1 was immunoprecipitated with Flag agarose resin and run through SDS-PAGE
before being immunoblotted for HA-tagged binding partners. (B) HEK 293 cells were transfected with Flag-tagged
WT, K122R, K122E, K122Q, or G93A SOD1 expression plasmids. Flag-tagged SOD1 was immunoprecipitated with
Flag agarose resin and run through SDS-PAGE before being immunoblotted for the CCS binding partner. (C) HEK
293 cells were transfected with Flag-tagged WT, G85R, K122R, K122E, or K122Q SOD1. SOD1 was
immunoprecipitated with Flag agarose resin and then competitively eluted with Flag peptide. The eluted SOD1 activity
was then measured calorimetrically. (n=3; **p<0.01, ***p<0.001; error bars are represented by +/- SEM) (D) Samples
were prepared as in (C) and the eluted SOD1 was resolved through Native-PAGE and SOD1 activity was assayed
within the gel. White bands indicate active SOD1.

buffering (9), and as a nuclear transcription factor (7, 8). In addition, a more recent study by Reddi
et al. demonstrated a novel function of yeast SOD1 in suppressing mitochondrial respiration
through modulation of casein kinase signaling (13). Given that lysine acylation is linked to
metabolism (31, 59, 60), we decided to test the potential link between the K122 PTM and SOD1
13

Figure 4. Acyl-K122 mimics of SOD1 inhibit SOD1-mediated suppression of mitochondrial respiration. (A)
Left: HEK 293 cells were transfected with Flag-tagged WT, K122R, K122E, or K122Q SOD1 expression plasmids
and oxygen flux was measured with an Oroboros O2K respirometer. Cell lysates were separated by SDS-PAGE and
immunoblotted for Flag-SOD1. (n=4; *p<0.05, **p<0.01; error bars are represented by +/- SEM) Right: HEK 293
cells were transfected with an empty vector or Flag-tagged WT, or G85R SOD1 expression plasmids and assayed as
in the left panel. (n=3; *p<0.05; error bars are represented by +/- SEM) (B) HEK 293 cells were transfected with an
empty vector or Flag-tagged WT SOD1 expression vector. Oxygen rates were measured with an Oroboros O2K
respirometer after CI inhibition with rotenone (2 mM) or CII inhibition with malonate (2.5 mM). (n=3 technical
replicates; **p<0.01; error bars are represented by +/- SEM)

anti-respiratory activity. To first test whether mammalian SOD1 suppresses respiration like its
yeast counterpart, we expressed WT human SOD1 in HEK-293 cells and saw a marked decrease
in mitochondrial oxygen flux, suggesting conservation of this SOD1 metabolic function from yeast
to humans (Figure 4A). Importantly, in comparing this effect on respiration across the panel of
acyl-mimicking SOD1 mutants, we found that the acetyl (K122Q)- and succinyl (K122E)mimicking mutants completely lost their ability to suppress respiration. Like yeast SOD1, the
inhibitory effect of mammalian SOD1 on respiration required its enzymatic activity, as the G85R
mutant, which shows ~70% reduced ROS scavenging activity compared to WT (Figure 3C), failed
14

to inhibit respiration like WT SOD1 (13). As an additional control, the K122R mutant was fully
active in suppressing respiration, suggesting that the K122Q and K122E phenotypes were not
simply due to mutation of the lysine, which could block other lysine PTMs, such as sumoylation
or ubiquitination (Figure 4A).
To determine which ETC subunit complex was affected by SOD1, we treated the SOD1expressing cells with inhibitors of complex I and II. While complex II does not transport protons
across the intermembrane space like complex I, the two complexes work in parallel to transfer
electrons to a pool of ubiquinone. Electrons from ubiquinone are then transferred step-wise to
complex IV where molecular oxygen is reduced to water. Because complex I and complex II work
in parallel to transfer electrons, each can be inhibited separately and electrons can still be
transferred through the uninhibited complex. When we inhibited complex II with malonate, SOD1
was still able to suppress respiration. However, when complex I was inhibited with rotenone,
SOD1 had no additional effect on respiration (Figure 4B), suggesting that SOD1 is inhibiting the
ETC at complex I.
SOD1-mediated inhibition of respiration can be modulated via SIRT5. Lysine
acylation is regulated by the activity of lysine deacylases (KDACs), which include the histone
deacetylase (HDACs) and Sirtuin families. Unlike many KDACs which prefer acetyl-lysine as
their substrate, SIRT5 shows preference toward the longer chain length acylations of succinylation
and malonylation (61). It was previously shown that SIRT5 is the desuccinylase for K122 (37)
and, while SIRT5 is traditionally thought of as a mitochondrial Sirtuin, recent studies have
described SIRT5’s presence in the cytosol as well (62-64). We validated the role of SIRT5 in
desuccinylating K122 by developing an antibody specific for succinylated K122 (Su-K122, Figure
5A). To confirm that succinylation occurs on endogenous SOD1, we depleted cells of SIRT5 and
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Figure 5. Development of an antibody specific to acylated K122 of SOD1; SIRT5 inhibition results in
succinylation of endogenous SOD1. (A) Flag-tagged WT or K122R SOD1 was overexpressed in HEK 293 cells with
or without SIRT5 knocked down by siRNA. Flag SOD1 was immunoprecipitated with Flag agarose resin, run through
SDS-PAGE and immunoblotted for succinyl-K122 (Su-K122) and total (Flag) SOD1. (B) Endogenous SOD1 was
immunoprecipitated from HEK 293 cells with or without SIRT5 knocked down via siRNA. The immunoprecipitated
SOD1 was then run through SDS-PAGE and immunoblotted with Su-K122 antibody. (n=3; *p<0.05; error bars are
represented by +/- SEM) (C) Flag-tagged WT or K122R SOD1 was overexpressed in HEK 293 cells with or without
SIRT5 knocked down by siRNA. Oxygen rates were measured with an Oroboros O2K respirometer. (n=3; **p<0.01,
***p<0.001; error bars are represented by +/- SEM)

immunoprecipitated SOD1. Figure 5B shows the increase in endogenous SOD1 succinylation at
K122 in SIRT5-depleted cells. Although acetylation of K122 clearly occurs on endogenous SOD1
((31, 55, 57, 58), proteomics data), our attempts to generate site-specific acetyl-K122 antibodies
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resulted in limited success—antibodies showed marginal specificity to the acetylation. This
complication, combined with the fact that K122E showed a slightly more robust effect in inhibiting
SOD1’s anti-respiration function, led us to focus primarily on K122 succinylation.
To determine whether we could block SOD1’s anti-respiratory activity by modulating the
endogenous deacylation machinery, we depleted SIRT5 in cells expressing WT or the nonsuccinylatable K122R SOD1 and measured respiration. Remarkably, we found that SIRT5
depletion recovered normal respiration levels in cells expressing WT SOD1 and the recovery was
overridden by the K122R mutant which cannot be acylated (Figure 5C). This suggests that SIRT5
modulates metabolism via desuccinylation of SOD1 at K122.
SOD1-mediated suppression of respiration is upstream of its mitochondrial
localization. SOD1 is known to reside in the cytosol, IMS of the mitochondria, and the nucleus
(28). Our respiration data made us question whether the anti-respiratory effect of SOD1 is exerted
locally within the IMS. If so, we would predict that acylation of K122 blocks SOD1 mitochondrial
localization. As shown in Figure 6A, we found decreased levels of the acyl-mimicking SOD1
mutants in the mitochondrial fraction. We included the ALS-linked G93A SOD1 mutant as a
positive control because it is known to accumulate in the IMS (Figure 6A, lane 2) (65). Shaw and
colleagues recently showed that neutralization of positively charged lysines by aspirin-induced
lysine acetylation on SOD1 inhibited its propensity to aggregate (23). However, the acylmimicking mutant, in the context of the ALS-linked G93A mutation, did not decrease SOD1
accumulation (Figure 6B). Together, these data suggest that acylation at K122 inhibits
mitochondrial accumulation of SOD1 and, while only correlative, they raise the possibility that
the mitochondrial pool of SOD1 may directly inhibit respiration in the IMS.
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Figure 6. SOD1-mediated suppression of respiration is upstream of its mitochondrial localization. (A) HEK 293
cells were transfected with Flag-tagged WT, G93A, K122Q, K122R, or K122E SOD1. The cells were lysed and
mitochondria were fractionated from the cytosol. The two fractions were run through SDS-PAGE and immunoblotted
for Flag-SOD1 present in the mitochondria vs. the cytosol. (B) Flag-tagged WT, G93A, or G93A/K122E SOD1 was
induced with tetracycline for 48 hours in T-REx 293 cells. The cells were lysed and the lysates were then loaded onto
a Superdex 200 10/300 GL Size exclusion column and eluted in fractions. The fractions were run through SDS-PAGE
and immunoblotted for Flag-SOD1 and endogenous SOD1. (C) Flag-tagged WT, CytB2-WT, or CytB2-K122E
SOD1 was overexpressed in HEK 293 cells. The cells were lysed and mitochondria were fractionated from the cytosol.
The two fractions were run through SDS-PAGE and immunoblotted for Flag-SOD1 present in the mitochondria vs.
the cytosol. (D) Flag-tagged WT, K122E, CytB2-WT, or CytB2-K122E SOD1 was overexpressed in HEK 293 cells.
Oxygen rates were measured with an Oroboros O2K respirometer. (n=3; **p<0.01, ***p<0.001; error bars are
represented by +/- SEM) (E) 1 nM rotenone or vehicle were added to HEK 293 cells 30 minutes prior to measuring
oxygen consumption rates with an Oroboros O2K respirometer. (n=4; ***p<0.001; error bars are represented by +/SEM) (F) 1 or 10 nM rotenone or vehicle were added to HEK 293 cells 30 minutes prior to lysing the cells and
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fractionating the mitochondria from the cytosol as in (A). The fractions were immunoblotted for the presence of
endogenous SOD1 in the mitochondria and cytosol. In each replicate, SOD1 levels were normalized to mitochondrial
and cytosolic loading controls and then normalized to the ratio of mitochondrial SOD1 in the 1 nM rotenone treated
sample. (n=6, ***p<0.001; error bars are represented by +/- SEM) (G) Flag-tagged WT-SOD1 was overexpressed in
HEK 293 cells. 1 mM 3-nitropropionic acid (3-NP) was added for 16-18 hours before the cells were lysed and
mitochondria were fractionated from the cytosol. The two fractions were run through SDS-PAGE and immunoblotted
for Flag-SOD1 present in the mitochondria vs. the cytosol. In each replicate, Flag-SOD1 levels were normalized to
mitochondrial and cytosolic loading controls and then normalized to the ratio of mitochondrial Flag-SOD1 in the 3NP treated sample. (n=3; ***p<0.001; error bars are represented by +/- SEM) (H) Flag-tagged G93A-SOD1 was
overexpressed in HEK 293 cells. 25 mM galactose in low glucose (2 mM) media was added 24 hours before the cells
were lysed and assayed as in (G). In each replicate, Flag-SOD1 levels were normalized to mitochondrial and cytosolic
loading controls and then normalized to the ratio of mitochondrial Flag-SOD1 in the untreated sample. (n=3;
***p<0.001; error bars are represented by +/- SEM) (I) An Erv1/MIA40 disulfide relay promotes the IMS import of
CCS, which in turn promotes the IMS retention of SOD1. The disulfide relay is reset when oxidized cytochrome c
accepts an electron from Erv1 (model adapted from Kawamata and Manfredi (67)).

Based on these data, our initial hypothesis was that acylation of K122 prevented SOD1
mitochondrial localization and thus blocked SOD1-mediated suppression of respiration. To test
this further, we used an approach in which SOD1 is appended, in frame, to the mitochondrial
import signal of Saccharomyces cerevisiae cytochrome b2 (CytB2) (66). Our prediction was
two-fold: First, that pushing WT SOD1 into the IMS would enhance SOD1-mediated suppression
of respiration; and second, that forcing the K122E SOD1 mutant into the mitochondria would
rescue its ability to suppress respiration. Figure 6C shows validation that the IMS targeting tag
resulted in robust accumulation of WT and K122E SOD1 in the mitochondrial fractions. However,
to our surprise, the mitochondrial localization of SOD1 did not enhance its ability to suppress
respiration (Figure 6D), nor did it recover the ability of the K122E mutant to suppress respiration.
This suggests that SOD1’s suppression of respiration is independent of its mitochondrial
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localization, which agrees with data from yeast in which the respiration-suppressing signal from
SOD1 originates in the cytosol (13).
An alternative explanation for the relationship between K122 acylation and SOD1
mitochondrial localization is that SOD1’s effect on respiration is upstream of its mitochondrial
localization. Indeed, there is evidence that the disulfide relay system that imports SOD1 into the
IMS is dependent on electron flux through cytochrome c reductase (complex III) of the ETC (68)
(69). Based on this model, up- or down-regulation of respiratory activity would cause a
corresponding decrease or increase in SOD1 mitochondrial localization. To test this, we first
identified a dose of rotenone, a complex I inhibitor, at 1 nM that produced a 10-15% reduction in
overall oxygen consumption (Figure 6E), similar to what we had observed with WT SOD1 in our
previous experiments. In support of the idea that inhibition of respiration drives mitochondrial
uptake of SOD1, treatment of cells with 1 nM rotenone for 30 minutes significantly increased the
accumulation of endogenous SOD1 in the mitochondrial pellet (Figure 6F). Additionally,
treatment of cells with 3-nitropropionic acid (3-NP), a complex II inhibitor, also triggered an
increase in mitochondrial SOD1 (Figure 6G). Conversely, boosting ETC activity by culturing cells
in galactose nearly eliminated the IMS-localized G93A mutant SOD1 from the IMS (Figure 6H).
These results suggest that cellular respiration levels modulate SOD1 mitochondrial uptake, such
that inhibition or stimulation of respiration can toggle SOD1 mitochondrial accumulation up or
down, respectively (model in Figure 6I). Furthermore, this suggests a potential feedback loop
between SOD1 acylation, inhibition of respiration and SOD1 mitochondrial import (see
discussion).
The SOD1 K122E acyl mimic is impaired in its ability to rescue the lethality of SOD1
deletion and reduce mitochondrial ROS levels. While SOD1’s vital role in direct
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disproportionation of cytosolic ROS is well established, our observation that SOD1 suppresses
respiration at complex I and the link between respiration and SOD1 mitochondrial import may
indicate an added dimension to SOD1’s role as an antioxidant. This is based on the decades-old
observation that the ETC is a source of ROS (70, 71) and the possible role of the mitochondrial
pool of SOD1 in scavenging ROS directly within the IMS (72, 73). The K122E mutant provided,
to our knowledge, the first tool to address this question genetically because it inhibits SOD1’s antirespiratory function while maintaining SOD1 enzymatic ROS scavenging activity. We took
advantage of an HCT-116 cell T-REx-based ‘flip-in’ system wherein a gene of interest can be
stably recombined with a specific locus under the control of a doxycycline (dox)-inducible
promoter. This provides the advantage of controlling for copy number, which allows for a more
fair comparison between different derived lines. After generating a panel of stable doxycyclineinducible SOD1 variants with silent mutations at PAM sites, we used CRISPR/Cas9 to delete
endogenous genomic SOD1 from each of the lines. Figure 7A shows that the inducible system
gives near-endogenous levels of WT and K122E SOD1 expression and is completely refractory to
the endogenous SOD1-targeted sgRNA. Of note, we had difficulty immunoblotting for G85R after
deletion of SOD1 due to the inability of G85R to rescue cells from the acute toxicity of SOD1 KO.
Previous studies have shown that SOD1 deletion in eukaryotes results in cell death as a
result of ROS accumulation (50, 51). Consistent with this observation, the SOD1 KO lines showed
a dramatic loss of cell growth as measured by an Incucyte live cell analysis system (Figure 7B—
upper panel shows basal growth rates without dox treatment) and infrared scanning of Giemsastained cultures after cell dilution and growth over a time course (Figure 7C). The loss of growth
caused by SOD1 KO was completely reversed in these cells by reconstituting WT SOD1
expression from the dox-inducible locus, indicating that growth defects were not due to off-target
21
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Figure 7. The SOD1 K122E acyl mimic is impaired in its ability to rescue the lethality of SOD1 deletion and
reduce mitochondrial ROS levels. (A) Endogenous SOD1 was knocked out of HCT-116 T-REx cells using the
CRISPR-Cas9 system. Expression of Flag-tagged SOD1 (with a mutated PAM site) was induced in the T-REx cells
with Doxycycline. The cells were lysed and subjected to SDS-PAGE before being immunoblotted for endogenous
SOD1 and overexpressed Flag-tagged SOD1. (B) Upper: SOD1 HCT-116 T-REx cells were seeded in 24-well plates
and grown in the absence of doxycycline. Cell confluence was measured by an Incucyte Zoom. Lower: SOD1 was
knocked out as in (A) and plated and analyzed as in (B; upper). (C) After knockout of endogenous SOD1 and
overexpression of Flag-tagged SOD1, the HCT-116 T-REx cells were seeded at 22,500 cells per well and allowed to
grow for 4 days before being fixed and stained with Giemsa. The wells were then imaged and quantified. (n=3
technical replicates; ***p<0.001; error bars are represented by +/- SEM) (D) Cells prepared as in (B) lower panel
were stained with JC-1 to measure mitochondrial membrane potential. A live-cell population was gated from FSC and
SSC measurements, and FL-1 was plotted against FL-2. Higher FL-2:FL-1 ratio indicates higher (healthier)
mitochondrial membrane potential. (E) Cells prepared as in (B) lower panel were stained with MitoSOX Red to
measure mitochondrial superoxide content. A live-cell population was gated from FSC and SSC measurements, from
which a population of singlets was identified and selected. A threshold for positive MitoSOX stain was set based on
the unstained control and a ratio of BL-3-positive cells to singlets was calculated and normalized to WT-add back
cells. Higher ratio indicates larger proportion of cells with superoxide present. (n=4; *p<0.05, ***p<0.001; error bars
are represented by +/- SEM) (F) Cells prepared as in (B) lower panel were stained with 5 µM MitoSOX Red for 10
minutes, and nuclei were counterstained. Prior to MitoSOX staining, positive control cells were treated with 30 µM
antimycin A for 40 minutes.

effects of the sgRNA. As a control, the G85R mutant, which shows reduced ROS scavenging and
does not inhibit respiration, was unable to rescue the growth defect in the SOD1 KO cells. In
contrast, SOD1 K122E, which is ROS scavenging-active but defective in inhibition of respiration,
showed an intermediate rescue of growth. JC-1 staining for mitochondrial membrane potential
showed a similar trend with a dramatic loss of membrane potential, a hallmark of oxidative stress,
in the SOD1 KO and G85R addback lines and a partial rescue of mitochondrial function in the
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K122E-expressing cells (Figure 7D). To measure ROS levels directly within the mitochondria of
each treatment, we used the MitoSOX mitochondrial ROS probe. Flow cytometric quantitation of
mitochondrial ROS mirrored the proliferation and JC-1 results, with WT SOD1 rescuing the
increase of mitochondrial ROS caused by SOD1 KO, and the K122E mutant showing a partial
rescue (Figure 7E). Representative confocal images of this experiment are shown in Figure 7F.
Together, these data suggest that SOD1-mediated dampening of respiration contributes to SOD1mediated cell survival. Possible mechanisms to explain this effect are discussed below.
DISCUSSION
We began this study with several affinity purification-based proteomics approaches to
identify PTMs across multiple tissues with the primary goal of finding new mechanisms of
regulation on cell survival signaling nodes. All proteomics data from this effort is freely available
(see link below under proteomics description). By using the machine learning approach of SAPHire (39), we prioritized several SOD1 PTMs for future study. Notably, a phosphorylation at S98
(or S99 depending on numbering scheme) showed the highest SAPH-ire score. This
phosphorylation sits within a solvent-exposed beta sheet of SOD1 and has been shown to regulate
SOD1’s role in transcription (7). It is also notable that seven SOD1 PTMs were grouped within a
high SAPH-ire score cluster, and all sit within a relatively small region spanning S98 to K128,
which includes part of the electrostatic loop.
We focused our initial studies on an acetylation within the electrostatic loop of SOD1 at
K122. This lysine was intriguing for several reasons. First, of the acylated lysines within the top
SAPH-ire cluster, it had the highest number of independent MS identifications (Figure 2A).
Second, it was conserved across multicellular eukaryotes and positioned within a known functional
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domain of SOD1. Third, we had previously identified this lysine as a Sirtuin substrate using a
biotin-switch approach in Xenopus egg extract (35), so its appearance in our proteomics data from
mouse tissue was striking. Lastly, during the course of this project, Lin and colleagues confirmed
the site as succinylated, which corroborated the lysine as a potentially important site of regulation,
as lysines that are acetylated are also commonly succinylated (55).
Two observations shed light on the potential mechanism by which acylation at K122
inhibits SOD1-mediated suppression of respiration. First, we found that the ROS scavengingimpaired SOD1 G85R mutant fails to suppress respiration, which agrees with data from yeast that
ROS-scavenging enzymatic activity is required for this new SOD1 function (13). Second, we
found that the acyl-mutants of SOD1, K122E and K122Q, fail to suppress respiration yet have
fully functional ROS scavenging enzymatic activity, which we confirmed through multiple assays.
In aligning these two observations, we reasoned that acylation at K122 may disrupt a proteinprotein interaction critical for suppressing respiration. Based on data from yeast, a clear candidate
SOD1 interactor is CK1γ (13). Unlike its yeast counterpart, human CK1γ has no clear analogous
C-terminal degron and we were unable to see the interaction by co-IP in human cells (limited by
antibodies with poor specificity). However, there are several isoforms of human casein kinase and,
interestingly, a sequence roughly matching the yeast CK1γ degron exists in the alpha isoform.
Ongoing efforts are exploring these possibilities. Furthermore, we attempted unbiased co-IP
proteomics to identify proteins that differentially interacted with SOD1 WT versus the K122E
mutant, but these provided strikingly few proteins (data not shown). In consulting with others in
the SOD1 field, this appears to be a fairly common observation and may indicate the need for
cross-linking or other approaches to stabilize SOD1-interacting proteins for capture. Nevertheless,
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our data support the idea that K122 acylation disrupts a SOD1 interaction that is critical for
suppression of respiration and our future efforts will focus on this mechanism.
In searching for a mechanism to explain the ability of K122 acylation to regulate SOD1’s
anti-respiratory activity, we found that acyl-mimicking SOD1 mutants differed from WT SOD1 in
that they failed to accumulate in mitochondria. This result initially led us to think that the acylK122 mutants failed to suppress respiration because they were unable to accumulate within the
IMS, where we presumed they were directly inhibiting the ETC. However, we found that forcing
the K122E mutant into the IMS with an IMS-targeting tag failed to recover its ability to suppress
respiration. In addition, the IMS-targeting tag did not confer additional respiration-suppressing
activity to WT SOD1. Nevertheless, this initially surprising result actually agrees with data from
Reddi and Culotta, in which they showed that yeast SOD1 suppresses mitochondrial respiration
from the cytosol by interacting with and stabilizing CK1γ (13).
Our observation that forcing the K122E mutant back into the mitochondria failed to recover
its ability to suppress respiration caused us to reconsider how SOD1 acylation and IMS
accumulation could be linked. Previous work suggests that the import of SOD1 into the IMS
depends on an Erv1/Mia40 disulfide relay system (reviewed in (67)). The activity of this disulfide
system is dependent on the oxidation of Erv1 by oxidized cytochrome c (74, 75). Therefore, under
conditions in which respiration is highly active, the ratio of reduced-to-oxidized cytochrome c
should increase, leading to a corresponding decrease in Erv1 oxidation and SOD1 mitochondrial
import. Conversely, a drop in respiration (causing a build-up of oxidized cytochrome c) would
increase SOD1 import into the IMS. In support of this model, we found that inhibiting respiration
led to accumulation of SOD1 in mitochondria fractions, while boosting respiration with galactose
caused a decrease in mitochondrial SOD1. Similar results have been observed in astrocytes (76).
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Taken together with the IMS phenotype of the acyl-SOD1 mutants, we favor the model that
acylation of SOD1 is upstream of SOD1 import into the IMS. Acylation of SOD1 blocks its antirespiratory function, which in turn decreases its import into the IMS. Conversely, we posit that
SOD1’s ability to suppress respiration feeds forward to drive its own IMS import and acylation
may serve as a brake on this mechanism.
In the bigger picture, an intriguing implication of this model is a potentially expanded view
of SOD1-mediated anti-oxidant defense--That SOD1-mediated suppression of respiration
contributes to its antioxidant/pro-survival function (see model in Figure 8). This could occur
through at least two possible mechanisms: 1) Inhibition of respiration drives SOD1 into the
mitochondria, placing SOD1 directly in position to scavenge ROS as it leaks from complex III. In
support of this idea, elevated mitochondrial SOD1 increases cell viability in a yeast system (73)
and mitochondria-targeted SOD1 rescues the loss of mitochondrial density observed in SOD1 null
mice (72). This model is intriguing as a variety of stresses, such as ischemia/reperfusion and cell
toxins, place strain on mitochondrial respiration and are known to cause spikes in mitochondrial
ROS (77). 2) Alternatively, the dampening of respiration at complex I by SOD1 may inhibit ROS
production directly. Interestingly, genetic inhibition of respiration partially rescues the loss of
viability caused by SOD1 deletion in yeast (78). Furthermore, metformin is known to suppress
mitochondrial ROS via inhibition of complex I (79-81). Exactly how this may occur is more
puzzling as our understanding of ROS generation from the ETC, and complex I in particular, is
limited. Prevailing dogma suggests that complex I only releases ROS into the matrix, but
depending on the point at which complex I is inhibited, it could dampen the reduction of
semiquinones or Fe-S clusters that may generate O2- elsewhere (82) or may simply reduce the flow
of electrons to complex III, a key producer of ROS within the IMS (77).
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Figure 8. Model: High levels of Sirtuin activity (SIRT5 for SOD1 succinylation) deacylate SOD1, which activates
SOD1’s respiration-suppressing activity at complex I. We posit that SOD1-mediated inhibition of respiration
contributes to SOD1-mediated cell survival through two potential (non-mutually exclusive) mechanisms: 1) Inhibition
of respiration increases the mitochondrial pool of SOD1, placing SOD1 directly in position to scavenge ROS leaking
into the IMS; 2) Dampening of respiration may directly reduce the production of ROS from the ETC.

We found that the impaired growth of SOD1 null cells, known to be caused by
accumulation of oxidative damage (27, 44, 45, 50, 78), could only be partially rescued by the
SOD1 K122E mutant, which is catalytically active against ROS but defective in inhibiting
respiration. Taken together, our data suggest that SOD1-mediated inhibition of respiration, while
clearly not the entire picture, may contribute to SOD1-mediated cell survival. Furthermore, the
link between IMS import of SOD1 and respiratory activity suggests a feedback loop in which
additional SOD1 may be recruited into mitochondria under conditions (e.g., mitochondrial damage
leading to ROS production) in which reinforced ROS scavenging would be needed.
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In summary, our data identifies, to our knowledge, the first acylation on SOD1 that
regulates its ability to suppress mitochondrial respiration. Given that Sirtuin activity is linked to
NAD+ levels, which, in turn, are linked to the overall metabolic state of the cell, SOD1 acylation
may act as a sensor to link nutrient metabolism to SOD1-mediated suppression of respiration. As
described above, this may provide an additional dimension to SOD1 antioxidant defense. These
data raise additional questions: Does SOD1 acylation disrupt a protein-protein interaction that
transmits the signal to complex I? Given that our data suggest that dampened respiration promotes
SOD1 mitochondrial import, could the toxic mitochondrial accumulation of ALS-linked SOD1
mutants in neurons be caused by an underlying perturbation of mitochondrial metabolism in a feed
forward loop? Answers to these and other related questions will help shed light on the increasingly
complex picture of SOD1 biology.
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CHAPTER 3: INSIGHTS INTO SOD1 AND AUTOPHAGY
INTRODUCTION
Macroautophagy (more generally referred to as autophagy) is a cellular recycling process.
Autophagy functions by engulfing targeted cargo with a single or double-walled membrane, fusing
with a lysosome, and degrading its contents, leaving basic building blocks and nutrients to be used
in new processes. It is associated with several identified roles in cell maintenance. For example,
Autophagy has been shown to support immune and inflammatory responses in multicellular
organisms (83). Kroemer, Marino, and Levine give an excellent review of the importance of
autophagy in response to a host of cellular stresses (84). In essence, autophagy plays an assistant
role to the proteasome and represents about 10% of total cellular protein/waste clearance with the
proteasome accounting for the other 90% (85). Interestingly, although there is some overlap in
cargo, the proteasome targets smaller, short-lived proteins while autophagy functions in turnover
of large to massive, longer-lived proteins (85). For example, autophagy targets misfolded proteins,
damaged protein complexes such as ribosomes, protein aggregates, and even whole organelles
including mitochondria (85).
Given the importance of autophagy in maintaining healthy cell function, it follows that
deficiencies in the autophagic program are problematic and can lead to cellular dysregulation or
disease. Indeed, inadequate or excessive autophagic activity have been implicated in Parkinson’s,
Huntington’s, Alzheimer’s, and Lou Gehrig’s diseases (86-90). And although autophagy does
play a role in protecting organisms from tumor cell transformation, beyond a specific stage in
tumor development autophagy can enhance tumor cell survival in nutrient-deficient conditions
(91).
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Autophagic flux can be estimated by several methods, including but not limited to
measuring relative levels of Microtubule-associated protein 1A/1B-light chain 3 (LC3) (an
extensive review on autophagy monitoring can be found in (92)). LC3-I is a soluble, 17 kDa protein
found in the cytosol. In an active autophagy scenario, LC3-I is converted to LC3-II when it is
covalently lipidated and inserted into the autophagosomal membrane. LC3-II is then degraded with
the rest of the autophagolysosomal cargo (93). Therefore, if the rate of LC3-II degradation is
controlled for or inhibited, the ratio of LC3-II to LC3-I indicates relative levels of autophagy flux.
Another method to track autophagic activity was demonstrated by Weerasekara et al., wherein
phospho signal at Ser 761 of ATG9a is indicative of active autophagy (94).
Autophagy can break down at several points whether chemically or physiologically,
leading to autophagic deficiencies. For example, there are several known chemical inhibitors of
autophagy that disrupt the process at early, mid, and late stage autophagy by known and unknown
mechanisms (95). In biology, however, it can be less clear how and why autophagy fails. For
example, several groups have shown that while effective and necessary for clearing aggregates and
inclusion bodies of alpha synuclein, beta amyloid and tau, huntingtin, and SOD1 as in Parkinson’s
disease, Alzheimer’s disease, Huntington’s disease, and Lou Gehrig’s disease (ALS), respectively,
autophagy can lead to undesired cellular outcomes (86-90).
Autophagy can break down at several points whether chemically or physiologically,
leading to autophagic deficiencies. For example, there are several known chemical inhibitors of
autophagy that disrupt the process at early, mid, and late stage autophagy by known and unknown
mechanisms (95). In biology, however, it can be less clear how and why autophagy fails. For
example, several groups have shown that while effective and necessary for clearing aggregates and
inclusion bodies of alpha synuclein, beta amyloid and tau, huntingtin, and SOD1 as in Parkinson’s
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disease, Alzheimer’s disease, Huntington’s disease, and Lou Gehrig’s disease (ALS), respectively,
autophagy can lead to undesired cellular outcomes (86-90).
Our preliminary results, though few, align with this information, and we offer additional
evidence to support the role of autophagy in cellular maintenance in the context of an ALS clinical
SOD1 mutant, SOD1 G93A. This chapter is highly preliminary in nature and represents a simple
groundwork for future experiments in the Andersen Lab. In this work, we find that overexpressing
G93A SOD1 with a second mutation (K122E) attenuates SOD1 mitochondrial localization, and
restores lower ATG9a pS761 levels seen in WT SOD1 expressing cells. We find by size exclusion
chromatography that both G93A and G93A/K122E SOD1 form high molecular-weight complexes
compared to WT, offering evidence that aggregate toxicity may be exerted from within the
mitochondria. We observe that mitochondrial content is reduced in G93A but not WT or
G93A/K122E SOD1 expressing cells. Finally, by combining heavy water labeling with TOF
LC-MS/MS we determine that overall protein turnover rates are increased in SOD1 G93A
expressing cells compared to WT SOD1 overexpression. Together, these results point to SOD1
accumulation as sufficient to boost cellular autophagy, particularly when SOD1 localizes to and
aggregates in the mitochondria.
RESULTS
Having previously established that WT SOD1, the deacyl-mimic K122R, and G93A SOD1
tended to localize to the mitochondria and that the SOD1 K122E succinyl-mimicking and K122Q
acetyl-mimicking mutants remained in the cytosol (see chapter 2, Figure 6A), we thought it
worthwhile to test the robustness of the effect of the K122 acyl-mimic mutations on SOD1 G93A
mitochondrial localization. We overexpressed WT, G93A, G93A/K122R, G93A/K122E, and
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G93A/K122Q SOD1 and after 48 hours, lysed the cells and enriched for mitochondria. To our
surprise, Western blot analysis revealed that the G93A/K122E and G93A/K122Q double mutants
showed highly reduced mitochondrial localization compared to G93A, G93A/K122R, and WT
SOD1 (Figure 1), indicating that the localization effect of K122 acylation is significant and robust.
To more reliably measure the effects of SOD1, we developed isogenic cell lines with (in
addition to an endogenous locus) a single inducible locus for WT, K122E, G93A, and
G93A/K122E double mutant SOD1. In these cells, expression of SOD1 was under the control of
a tetracycline-inducible promoter. We verified by immunoblot analysis that continuous induction
over a time course led to continued increase of SOD1 expression. Interestingly, we observed that
from equal quantities of cell lysate, at 72 hours of induction and beyond, WT SOD1 levels stayed
constant but beta actin levels decreased (data not shown). Given that beta actin is a long-lived
protein, this piqued our interest and led us to explore the possibility that autophagy was highly
active in these cells after prolonged overexpression of SOD1. To measure autophagic activity,
T-REx 293 SOD1 Flp-In cells were transfected with HA-ATG9a. At the time of transfection, cells
were also treated with tetracycline to induce expression of WT, G93A, and G93A/K122E (double
mutant) SOD1. After 48 hours, we immunoprecipitated HA and measured ATG9a pS761 levels
with a 14-3-3ζ phospho-binding motif antibody validated for measuring pS761 levels on ATG9a
(94). As shown in Figure 2, phospho signal was elevated in SOD1 G93A-expressing cells
compared to WT. Of note, the double mutant showed a marked reduction of pS761 ATGa, more
so than for WT SOD1. Given the differential tendencies of these SOD1 constructs to localize to
the mitochondria or stay in the cytosol, these data strongly suggested that SOD1 aggregation was
activating higher autophagy levels when it occurred in the mitochondria. This would imply that
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Figure 1. K122E succinyl-mimic mutation reverses mitochondrial localization of SOD1 G93A. HEK 293 cells
were transfected with Flag-tagged WT, G93A, G93A/K122R, G93A/K122E, or G93A/K122Q SOD1. The cells were
lysed and mitochondria were fractionated from the cytosol. The two fractions were run through SDS-PAGE and
immunoblotted for Flag-SOD1 present in the mitochondria vs. the cytosol. (n=3 technical replicates; *p<0.05,
**p<0.01; error bars are represented by +/- SEM)

the effect of the K122E mutation, in the context of G93A, is limited to SOD1 localization, and
does not influence the propensity of G93A SOD1 to aggregate.
To test this idea, we induced expression of WT, G93A, and G93A/K122E SOD1 for 48
hours, lysed the cells, and subjected them to gel filtration analysis. Indeed, Western blot analysis
of the gel filtration fractions showed both G93A and G93A/K122E SOD1 eluting in
high-molecular weight fractions, compared to WT and endogenous SOD1 (see Chapter 2 Figure
6B). Given our data showing G93A SOD1 localized heavily to the mitochondria, and
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Figure 2. K122E succinyl-mimic mutation rescues lower ATG9a pS761 levels of SOD1 G93A. T-REx 293 SOD1
Flp-In cells were transiently transfected with HA-ATG9a. At the same time, cells were treated with tetracycline to
induce expression of WT, G93A, or G93A/K122E SOD1. After 48 hours, cells were harvested, lysed, HA was
immunoprecipitated, and ATG9a pS761 levels were measured by Western blot. (n=3 replicates; error bars represent
+/- SEM)

G93A/K122E SOD1 primarily in the cytosol, these data suggest that the location of SOD1
aggregation does matter. They also suggest that the autophagy program being activated was one
targeted specifically to mitochondria—a process known as mitophagy.
To further determine whether mitophagy was the main autophagic mechanism at play, we
looked for a method to measure total cellular mitochondrial content. Complex IV of the
mitochondrial electron transport chain (ETC) is composed of many conserved subunits, one of
which is cytochrome c oxidase subunit 2 (MTCO2), thus making it a reliable readout for relative
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Figure 3. Mitochondrial content is reduced in G93A and K122 deacyl-mimic SOD1. HEK 293 cells were
transiently transfected with WT, G93A, G93A/K122E, or G93A/K122Q SOD1, or with no DNA. Cells were
harvested, lysed, and subject to Western blot analysis.

mitochondrial content within cell populations. We overexpressed WT, G93A, G93A/K122E, and
G93A/K122Q SOD1 in HEK 293T cells and measured MTCO2 levels compared to a mock
transfection and a positive mitophagy control population treated with CCCP, a known inducer of
mitophagy (96). Western blot analysis revealed that in the mock, WT, and double mutant cells,
mitochondrial content was relatively equal, compared to a marked reduction of MTCO2 in the
CCCP and G93A SOD1 populations (Figure 3). These data indicate that the G93A SOD1
expressing cells have reduced mitochondrial content, suggesting that the mitochondria in those
cells are being subjected to a degradative process. This conclusion, however, is limited in that we
have only a single measurement. Several more replicates would greatly assist in drawing a reliable
conclusion.
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Figure 4. D2O labeling coupled with LC-MS/MS reveals increased protein turnover rates in SOD1 G93A
expressing cells compared to WT SOD. T-REx 293 SOD1 Flp-In cells were treated with tetracycline for 24 hours
to induce expression of WT, K122E, G93A, and G93A/K122E SOD1. Cells were then treated with DMEM containing
5% deuterium oxide (v/v) and cells were harvested at time points of 0, 8, 16, and 24 hours of D2O treatment. Cells
were lysed and lysates were prepared for mass spectrometry analysis. Protein turnover rates were determined by an
in-house modification of DeuteRater. See Methods for more detail. Red color indicates higher ratio of
degradation/synthesis rates; blue color indicates lower ratio of same rates. White represents anything between lower
and higher extremities.

To more precisely detect mitochondrial turnover in these cells, we used a novel method for
tracking total protein production and degradation rates across several time points, developed by
the J. C. Price Lab and based on heavy water labeling coupled with time-of-flight LC-MS/MS. We
induced expression of WT, G93A, K122E, and G93A/K122E SOD1, in addition to a control
population, for 24 hours before labelling cells with 5% deuterium oxide (D2O) in complete
DMEM. At time point zero (just prior to addition of D2O) we harvested and froze one set of cells,
and then added D2O to the remaining cells. We then harvested cells at 8, 16, and 24 hours for a
total of four time points. This would give the cells time to double approximately one time, based
on our measurements, thus allowing enough time and growth for an intermediate, but not
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overwhelming, amount of protein labeling. Following harvest, cells were prepared for and subject
to mass spec analysis. The resulting spectra were validated and analyzed with an in-house program
(see Methods chapter) and subsequently quantified. The analysis unexpectedly revealed that,
compared to WT, G93A SOD1 cells exhibited globally increased protein turnover rates, and not
just increased mitochondrial protein rates (Figure 4), suggesting that mitophagy was active, but
other forms of macroautophagy may also be active. These results, though unexpected, are not
surprising given that we initially observed decreasing quantities of beta actin. Furthermore, they
align with the elevated or lowered ATG9a pS761 levels we measured in the same cell lines (see
Figure 2). Taken together, these results suggest that toxic SOD1 accumulation in the mitochondria
is sufficient to activate a global program of cellular autophagy, including mitophagy, and that
SOD1 accumulation may not be nearly as toxic if kept outside of the mitochondria.
DISCUSSION
In our efforts to better characterize the robustness of the SOD1 K122E succinyl-mimic in
keeping SOD1 out of the mitochondria, we found that succinylation has the potential to abrogate
SOD1 G93A localization to the mitochondria almost entirely. However, we found that SOD1
G93A and the G93A/K122E double mutant both still aggregate. What is intriguing is that between
the two, only G93A SOD1 increases autophagic activity. Therefore, we conclude that the location
of the accumulation is crucial in determining whether or not the protein accumulation is toxic. It
would be even more enlightening to look at survival and growth rates of cells with this model to
further assess toxicity.
Furthermore, the D2O-mass spectrometry data show an overall increase in protein turnover
rates in G93A SOD1-expressing cells, which aligns with our measured increase in ATG9a pS761
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signal. While many investigators have observed stalled or deficient autophagy in
neurodegenerative models, it is reasonable to argue that our work actually agrees with the overall
picture because in order for autophagy to become overwhelmed it must arguably be overactive
first. Our work may more accurately represent the beginning stages where autophagy is overactive,
given that we only overexpress SOD1 for 48 to 72 hours. This amount of time might be insufficient
to mimic a late stage ALS patient or mouse model.
It is important to note that the initial connection we made between SOD1 and autophagy
was based on extended overexpression of WT SOD1, and not the G93A clinical mutant. We have
not looked at ATG9a pS761 levels in that context, but that would be valuable. If it was indeed
increased autophagy activity that caused the observed decrease in actin, this would strengthen our
working hypothesis that autophagy can be initiated globally as a result of mitochondrial protein
overload; indeed, both WT and G93A SOD1 localize to the mitochondria. However, more work
would need to be done to characterize which types of autophagy are activated in response to
mitochondrial stress, given that our initial observation was decreasing actin. It would be useful to
measure indicators of other forms of autophagy, such as ribophagy, to more correctly characterize
the mechanisms induced by mitochondrial accumulation of SOD1.
Finally, the fact that the double mutant can reduce mitochondrial SOD1 import and rescue
autophagic deficiencies suggests that we have a potential tool for mitigating the toxic effects of
mutant SOD1 in fALS. If the experiments can be repeated with fidelity and show statistical
significance, we could have a method to reduce or delay the proteotoxic effects observed in some
neurodegenerative diseases that include SOD1.
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CHAPTER 4: DISCUSSION
The importance of lysine acetylation and succinylation have recently emerged, especially
in the context of cellular and metabolic regulation. These, along with phosphorylation and other
post-translational modifications (PTMs) have proven to be the means of integrating complex
metabolic signals in a rapid, adaptive manner. Given the overwhelming evidence that metabolic
dysregulation frequently leads to disease, we initially set out to identify specific PTM-regulated
proteins, and to find where those modifications were happening. Our proteomics results revealed
several candidates, including SOD1. Indeed, our overall results identified SOD1 as a protein with
a PTM-driven regulatory mechanism. Specifically, acetylation- and succinylation-mimicking
mutations (acylation) of SOD1 K122 abolish the ability of SOD1 to repress respiration and
prevents its import into the mitochondria, without perturbing canonical SOD1 antioxidant
function. Furthermore, based on our cell growth/survival, mitochondrial membrane potential, and
mitochondrial ROS measurements, we observed that deacylated SOD1-mediated suppression of
respiration resulted in improved mitochondrial health/function and promoted resilience to stress.
Therefore, acylation of SOD1 K122 represents a potential and novel target for treatment of SOD1
pathologies. However, more work is required before those strategies can be developed.
Interestingly, in contrast to the beneficial effects observed in WT SOD1-expressing cells,
wherein SOD1 localizes to the mitochondria, G93A SOD1 which also accumulates in the
mitochondria, has shown an opposite effect in G93A mouse models. These models are well known
to develop symptoms identical to an ALS patient, including motor neuron death, and eventual
mortality. Therefore, it is possible that within a cell, it may be part of a survival or defense
mechanism to import SOD1 into the mitochondria under stressed conditions, however if that SOD1
is prone to aggregate, as with the G93A mutant, this could lead to unintentional and irreversible
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toxicity. Indeed, our data show decreased mitochondrial content and increased autophagic flux
when SOD1 G93A is overexpressed, suggestive of just such irreversible mitochondrial damage,
assuming mitochondria are being engulfed and degraded through autophagy. Furthermore, given
that WT SOD1 represses respiration, and that our data suggest that dampened respiration promotes
SOD1 mitochondrial import, it is possible that any folded G93A is also repressing respiration,
which would drive more SOD1 into the mitochondria in an irreversible feed forward loop. This
contrasts with WT SOD1, which does not aggregate.
It is clear from our data that SOD1 exerts its regulatory effect on respiration upstream of
import into the mitochondria, however as mentioned in Chapter 2, the underlying molecular
mechanism is unknown. It is possible that altering the acyl state of SOD1 K122 introduces steric
hindrance or a conformation change sufficient to preclude an interaction with putative binding
partners involved in respiratory signaling. For example, as hinted at in the Discussion in Chapter
2, SOD1 in yeast binds to the C-terminal degron of casein kinase 1 gamma (CK1γ), which
propagates the anti-respiratory signal through the Wnt signaling pathway. And in mammalian
cells, the alpha isoform of CK1 has a similar degron sequence. It is possible, then, that SOD1 could
bind to the alpha isoform. However, this may not be the case given that in the yeast ortholog,
SOD1 entirely lacks a lysine at the relative aligned position (see Figure 2F in Chapter 2).
To study the interaction of SOD1 with CK1, we plan to use an overexpression system with
three isoforms of CK1 coupled with mass spectrometry, immunoprecipitation, and confocal
microscopy. As previously mentioned, SOD1 shows a limited number of interactors when subject
to immunoprecipitation and mass spectrometry, therefore we may need to include a crosslinking
step in those experiments. Alternatively, we have developed a BirA-SOD1 construct that expresses
a BioID-SOD1 fusion protein capable of biotinylating any proteins that come within proximity of
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SOD1. This would enable a streptavidin-based immunoprecipitation of proteins that potentially
interact with SOD1, whether transient or long-term. Immunoprecipitated targets could then be
analyzed via mass spectrometry and Western blot. This strategy may provide a reliable method for
revealing SOD1 interactors, including any involved in regulating mitochondrial respiration.
In Figure 7 of Chapter 2, we examine the effects of different acyl-mimicking forms of
SOD1 K122 on cell growth and survival via a knock-out/add-back approach. It would be valuable
to KO endogenous SOD1 in the T-REx Flp-In SOD1 CytB2 K122E cell line as well as in CytB2
WT SOD1, induce expression of these mitochondria-targeted SOD1 constructs, and see whether
growth phenotypes more closely resemble those of WT or K122E SOD1.
In chapter 2 we address the effect of depleting SIRT5 on endogenous levels of SOD1 K122
succinylation. In light of the growth and survival studies conducted in the T-REx HCT-116 Flp-In
SOD1 system, it would be informative to repeat those experiments in just the WT SOD1 cells, in
the presence or absence of SIRT5 interfering RNA. We would postulate that when SIRT5 is
knocked down, cells would more closely resemble the K122E succinyl mimics. To accompany
that study with fractionation and mitochondrial enrichment to measure localization of SOD1 would
also be very informative. It seems likely that if SIRT5 were depleted, less SOD1 would be found
in the mitochondria. And in this same system, it would be interesting to measure mitochondrial
ROS levels in WT SOD1 cells with or without SIRT5 depletion. I would hypothesize that depleting
SIRT5 would lead to increased mitochondrial ROS, similar to what was measured in SOD1 K122E
expressing cells in Chapter 2 Figure 7E.
As yet, we do not know the clinical relevance of our results. To work towards that, we are
conducting xenograft studies with mice inoculated with T-REx HCT-116 Flp-In SOD1 WT and
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K122E cells. We anticipate that the SOD1 WT-treated mice will develop larger, more aggressive
tumors, while those treated with SOD1-K122E cells should show tumors with a comparatively
smaller volume. Preliminary feedback indicates that there may be issues with the way in which
doxycycline is being administered (in food pellets), and that putting it in their water may be more
effective. Final analysis and evaluation will be available soon.
Finally, as part of our initial efforts, a SAPH-ire based analysis (see Figure 2A-2D in
Chapter 2) revealed that there are at least six more SOD1 residues that are modified by PTMs at
high frequency within a biologically relevant region of SOD1. These residues will serve as a
valuable platform for future SOD1 studies and may contribute even more insight into SOD1’s
complex mode of regulation.
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CHAPTER 5: MATERIALS AND METHODS
Mass Spectrometry and PTM Affinity Purifications. Trypsin-digested cell lysates from
mouse embryo, brain, and liver were prepared by lysis in 8 M urea, followed by normalization to
approximately 2 mg/mL and 1.8 M Urea, reduced with 10 mM dithiothreitol, alkylated with 20
mM iodoacetamide, and digested with TPCK trypsin at 1:25 w/w. Peptides were desalted with
C18 SPE cartridges (Waters) and lyophilized to dryness. Approximately 5 mg aliquots of each
lysate digest was enriched for post-translational modifications using the PTMScan product line
(Cell Signaling Technologies), including a series of phospho-specific motifs (AKT, MAPK,
phosphothreonine, or pY) as well as ubiquitin remnant (GG-K), or acetyl-lysine (Kac), as
previously described (97-99). Titanium dioxide enrichment was performed as previously
described, for comparison (99).
After immunoaffinity or titanium dioxide enrichment, peptides were analyzed using datadependent acquisition (DDA) by a 3-fraction LC/LC-MS/MS method as previously described
(100). Samples were resuspended in 12 µl of 1/2/97 v/v/v TFA/MeCN/water. Phosphopeptide
samples additionally contained 20 mM citric acid. Approximately half of each sample was
analyzed on a 2D nanoAcquity UPLC coupled to a Synapt G2 HDMS (Waters Corporation).
Searchable files (*.mgf) were generated from raw data in Mascot Distiller, and database searching
for peptide ID and Mascot search engine v2.4 (Matrix Science, Inc.). The UniProt database
(www.uniprot.org) with mus musculus taxonomy and reviewed status was utilized, along with 10
ppm precursor and 0.04 Da product ions. Fixed modification of Cys with carbamidomethylation
was required, and variable modifications included deamidation NQ, oxidation M, along with
acetylated K, ubiquitin remnant), or phosphorylated S/T/Y. Full tryptic specificity was required.
Data was curated in Scaffold v4.7 using PeptideProphet algorithm, to a 0.05% peptide and 0.4%
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protein

FDR.

The

Scaffold

file

is

available

for

download

at

https://discovery.genome.duke.edu/express/resources/3023/3023_PTMScanAll_withTiO2.sf3.
All mouse experiments were IACUC approved.
SAPH-ire. SAPH-ire FPx was employed as described previously (39), with modifications
for the domain-specific analysis of the superoxide dismutase (SOD) copper/zinc binding domain
(IPR001424). FPx scores were calculated using the structure-free 8-factor neural network model
as described previously (38). The SOD domain sequences for all eukaryotic proteins were obtained
from Pfam (101). The multi-FASTA files generated for the domain family were subsequently
aligned using MUSCLE with default parameters (102). The domain dataset for SOD contained 79
unique sequences within which 77 distinct PTMs could be retrieved from the public domain. PTMs
coalesced into 34 modified alignment positions (MAPs) in the family, the features of which were
used for SAPH-ire FPx scoring.
Cell Culture and Reagents. HEK 293T cells were purchased from ATCC. Flp-In T-REx
293 host cell line was purchased from Thermo Fisher Scientific (R78007). The Flp-In T-REx
HCT-116 host cells were developed by Dr. Stephen Taylor (103). All cell lines were cultured in
Dulbecco's modified Eagle's medium (DMEM, Gibco no. 11965) supplemented with 10% fetal
bovine serum (FBS) at 37 ºC in a 5% CO2 incubator.
Antimycin A (A8674), 3-Nitropropionic acid (3-NP) (N5636), galactose (G5388),
tetracycline (T7660), doxycycline (D3447), and CCCP (C2759) were purchased from Sigma.
Rotenone was purchased from Millipore (557368). Drugs used in cell culture were dissolved in
the recommended solvent and then diluted in cell culture media to the indicated final
concentrations.
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Plasmid Transfections and siRNA. Cells were transfected with plasmid expression
vectors pcDNA3.1, HA- or FLAG-SOD1, or HA-Atg9 (gift from Dr. Luigi Puglielli at the
University of Wisconsin) with polyethylenimine (PEI, Polyscience Inc.) transfection reagent in a
1:3-4 (µg DNA:mg PEI) ratio. Site-directed mutants of FLAG-SOD1 were generated using the
Agilent QuikChange II XL kit (200521) or the Q5 Site Directed Mutagenesis kit from New
England Biolabs, Inc. (E0554). Plasmids and selection reagents for Flp-In T-REx host cell lines
were obtained from Thermo Fisher Scientific. RNAiMAX Lipofectamine reagent was purchased
from Invitrogen (13778100). Smartpool siRNA against SIRT5 was obtained from GE Dharmacon
(M013448010005). The Cytochrome B2 SOD1 cDNA was obtained from Dr. Giovanni Manfredi.
Generation of Flp-In T-REx Cell Lines. Generation of T-REx cells lines with
Flp-recombinase mediated gene insertion allows for tight control of expression of a gene of interest
at a single, actively transcribed genomic locus by addition or removal of tetracycline or its
derivatives. For further explanation, refer to the manufacturer’s manual (Thermo Fisher Scientific
no. R78007).
T-REx

host

cells

were

transiently

transfected

with

pOG44

and

pcDNA5/FRT/TO-FLAG-SOD1, including WT SOD1 and acyl-mimicking mutants, at a ratio of
9:1 (pOG44:pcDNA5). Constructs were co-transfected into cells in 6-well plates when cells were
approximately 60% confluent. After 48 hours, cells were trypsinized and transferred to 15 cm cell
culture dishes and cultured in complete medium containing 150 µg/mL of hygromycin B selection
reagent (Gibco 10687010). After 10 days, single colonies were transferred to individual wells of a
24-well plate and cultured in medium without selection reagent. Plates were replicated and
expression was induced for 24 hours with 1 µg/mL tetracycline in one set of the replicates, after
which cells were harvested, lysed, and subjected to Western blot analysis as described below. Cells
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positive for the FLAG epitope were selected, and cells with the lowest background expression
when not induced, but still exhibiting high inducible expression with tetracycline, were selected
for use in experiments. For experiments, expression was induced with either tetracycline or
doxycycline at a final concentration of 100 ng/mL.
Antibodies. Primary mouse monoclonal anti-HA (7392), rabbit polyclonal anti-FLAG
(807), mouse monoclonal and rabbit polyclonal anti-beta actin (8432, 1616) were purchased from
Santa Cruz Biotechnology. Primary mouse monoclonal anti-FLAG (8146), rabbit polyclonal antiFLAG (2368), mouse monoclonal and rabbit polyclonal anti-human SOD1 (4266, 2770), mouse
monoclonal anti-HA (2367), rabbit monoclonal anti-SIRT5 (8779), rabbit polyclonal anti-VDAC
(4661), and mouse monoclonal phospho-serine 14-3-3 binding motif (9606) were purchased from
Cell Signaling Technology, Inc. Primary mouse monoclonal anti-GAPDH and rabbit monoclonal
anti-MEK1/2 were purchased from Abcam (9484, 178876). Anti-mouse and anti-rabbit IRDye
680RD and IRDye 800CW secondary antibodies were purchased from Licor (92668070,
92632210, 92668071, and 92632213).
Succinyl-Lys122 Antibody Purification: Rabbits were immunized against the succinylatedSOD1 peptide (LVVHE[succinyl-K]ADDLGC) and serum was collected. Succinyl-Lys122
polyclonal antibody was immunopurified out of serum using succinylated Lys122 SOD1 peptide
as previously reported (104). In brief, biotinylated (non-succinyl) Lys122 peptide was conjugated
to streptavidin-agarose (20359, Thermo Scientific) and gently rotated at 4 ºC overnight with rabbit
serum diluted 1:1 in equilibration buffer (150 mM Tris [pH 7.5], 20 mM NaCl) to deplete nonsuccinyl Lys122-specific antibody from serum. Following incubation, serum was transferred to a
column containing succinylated Lys122 peptide conjugated to streptavidin resin and again
incubated overnight with gentle rotating. Resin was thereafter washed twice with equilibration
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buffer. Succinyl Lys122-specific antibody was then eluted from resin with elution buffer (0.1 M
glycine-HCl [pH 2.8]) by gravity elution. Fractions were then collected in microfuge tubes and
neutralized with neutralization buffer (1 M Tris-HCl [pH 8.5]). Reactivity of each fraction was
tested via Western blot for antibody titer.
Primary anti-human SOD1 succinyl-Lys122 antibody serum, biotinylated SOD1 succinylLys122 peptide, and biotinylated SOD1 non-succinyl Lys122 peptide were produced by Eton
Bioscience, Inc.
Western Blotting and Immunoprecipitation. Cells were seeded in 10 cm or 6-well plates
to 15% confluence. After 24 hours, at about 30% confluence, T-REx cells were induced, or non
T-REx cells were transfected with a SOD1 expression vector, an empty vector, or mock
transfected. After 8 hours, cell culture medium was replaced with complete medium and incubated
at 37 ºC in a cell culture incubator until 48 hours post-transfection. Cells receiving drug treatment
were treated within this incubation time at the indicated concentrations. Cells treated with RNA
interference were transfected with 100 nM SIRT5-directed or scrambled siRNA with RNAiMAX
Lipofectamine. The knock-down was repeated to ensure efficient depletion of SIRT5. Then cells
were allowed to grow 24 to 48 more hours. Following transfection and incubation, cells were
washed twice and harvested with ice-cold PBS. Cells were then lysed in ice-cold
coimmunoprecipitation buffer (10 mM HEPES [pH 7.5], 150 mM KCl, 0.1% NP-40) or TNTE
coimmunoprecipitation buffer (20 mM Tris [pH 7.8], 150 mM NaCl, 0.3% w/v triton X-100, 5mM
EDTA), supplemented with protease inhibitors (88665 Pierce). Lysates were then cleared by
centrifugation at 21,000 x g for 10 minutes at 4 ºC. Lysate protein concentration was determined
by a Bio-Rad protein determination DC Assay (5000116). Lysate was saved for analysis or
incubated with 15 µL of anti-FLAG-agarose resin (2220 Sigma). Protein was eluted from the resin
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by incubation with modified Laemmli buffer for 5 minutes at 100 ºC. Lysates were likewise mixed
and boiled in modified Laemmli buffer. Samples were then loaded onto SDS PAGE gels. Bluestain
protein ladder (P007 GoldBio) was used as a molecular weight reference. Gels were then
transferred to a PVDF membrane and immunoblotted for proteins of interest. Proteins were
visualized and bands were quantified using the LI-COR Odyssey Classic or CLx imaging systems
and Image Studio software package.
SOD1 Activity Assays. For the in vitro colorimetric activity assay, HEK 293T cells were
transfected with a FLAG-SOD1 plasmid or mock transfected. Cells were harvested, lysed, and
FLAG was immunoprecipitated with FLAG epitope-conjugated agarose beads, after which the
resin was washed 3x in cold PBS. FLAG-SOD1 was then competitively eluted from the beads by
incubation in a 200 ng/µL solution of purified FLAG peptide (Apex Bio), with gentle shaking for
10 minutes at 4 ºC. Beads were then centrifuged at 8,200 x g for 30 seconds at 4 ºC. The
FLAG-SOD1-containing supernatant was transferred to a new microfuge tube and the elution was
repeated and added to the same tube. With the purified SOD1 or mock supernatants, SOD1 ROS
scavenging activity was indirectly measured using a SOD Assay Kit purchased from Sigma
(19160), according to manufacturer’s recommendations.
For the in situ SOD1 activity gel, purified FLAG-SOD1 was produced as in the
colorimetric assay. SOD1 ROS scavenging activity was indirectly measured as a competitive
reaction of superoxide with nitroblue tetrazolium (NBT) dye as previously described (105).
Briefly, a portion of the purified SOD1 supernatants were mixed with 5x SOD loading dye (25
mM Tris-HCl [pH6.8], 50% glycerol, 0.5% bromophenol blue) to a final concentration of 1x
loading dye. Samples were then loaded onto an 8% native PAGE gel and SOD1 was resolved at
80 V constant until the loading dye reached the end of the gel. The gel apparatus was maintained
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at 4 ºC. The gel was then moved to a shallow container, immersed in 50 mL of staining solution
(45 mM K2HPO4, 4.6 mM KH2PO4, 0.163 mM NBT, 0.266 mM riboflavin), and covered with foil.
50 µL of TEMED was then added and the gel was incubated with gentle shaking for 1 hour in the
dark. Following incubation, the staining solution was removed and the gel was washed 2x with
distilled water, and then immersed and incubated in distilled water with gentle shaking overnight,
while exposed to ambient light. Clear bands on the blue-stained gel were interpreted as active
SOD1. NBT (N6639), K2HPO4 (P3786), KH2PO4 (P0662), and riboflavin (R9504) were purchased
from Sigma.
Cell Survival Assay. Single-guide RNA (sgRNA) against SOD1 was cloned into the
pSpCas9(BB)-2A-Puro (PX459) vector. PX459 was a gift from Feng Zhang (Addgene plasmid #
48139) (106). Human codon–optimized Cas9 from S. pyogenes and the sgRNA were expressed
from the human cytomegalovirus (CMV) immediate early promoter and the human U6 promoter,
respectively.

The

SOD1-targeted

20

base

pair

sgRNA

contained

the

sequence

TTGCATCATTGGCCGCACAC with an NGG protospacer adjacent motif (PAM) site of TGG.
Knock-out efficiency was measured via Western blot analysis. The construct was transfected into
T-REx HCT-116 cells. After eight hours, transfection medium was removed and replaced with
DMEM complete medium. 24 hours post-transfection, cell culture medium was replaced with
DMEM complete medium containing 3 µg/mL puromycin selection reagent. After 48 hours,
selection medium was removed and replaced with DMEM complete medium containing 100
ng/mL doxycycline. Doxycycline medium was replenished every 48 hours and cells were
trypsinized as needed. Cells were allowed to grow until there were sufficient cells for the assays,
after which cells were trypsinized and counted.
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Growth Assay with Giemsa Stain: For Giemsa staining, 22,500 cells per well were seeded
into 6-well plates with 100 ng/mL doxycycline and allowed to grow for 5 days. Cells were then
washed twice with ice cold PBS, fixed for 30 minutes in ice cold methanol at 4 ºC, after which
methanol was aspirated and a 1:20 mixture of Giemsa stain (Fluka Analytical 48900) to PBS was
added to cells and incubated at room temperature for 45 minutes. Following staining, cells were
washed 3 times with distilled water and allowed to air dry. Wells were imaged and quantified using
the LI-COR Odyssey Classic imaging system and Image Studio software package.
Incucyte Zoom Analysis: For Incucyte analysis of control cells without SOD1 knockout,
12,500 cells were seeded per well into 12-well plates. For the SOD1 knockout/addback cells
18,000 cells were seeded per well into 24-well plates. Plates were put into the Incucyte one day
after seeding and cell confluence was monitored via basic phase contrast analysis for 80 to 120
hours. Cell confluence was given as the mean of 4 wells per sample, 16 images per well. Error
bars are represented as +/- SEM.
Cellular Respiration. HEK 293T cells were transiently transfected with 8 μg of a SOD1
plasmid, empty pcDNA3.1, or mock transfected. Eight hours later, cell culture medium was
replenished and cells were allowed to grow for a total of 48 hours. For rotenone treatment, 1 nM
rotenone or vehicle was added to HEK 293 cells 30 minutes prior to measuring oxygen
consumption rates, and incubated at 37 ºC in 5% CO2 atmosphere. Cells were then detached in
culture dishes with 0.05 % trypsin–EDTA (Gibco) and growth medium was added to the culture.
Contents were transferred to a 15 mL conical tube and centrifuged at room temperature. After
removal of supernatant, the cells were permeabilized, prepared for the Oroboros O2K (Oroboros
Instruments, Innsbruck, Austria), and O2 flux was measured as previously described by Hodson et
al. with the exception of a few changes as outlined below (107). The data presented is taken from
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maximal O2 flux measurements when the full electron transport system capacity of oxidative
phosphorylation was measured after addition of FCCP. For the complex I and complex II inhibition
assay, rotenone (2 mM) and malonate (2.5 mM) were added prior to O2 flux measurements. After
respiration was measured, cellular protein concentrations from the same cells were determined as
in ‘Western Blotting and Immunoprecipitation’. For the rotenone treated cells, 2 million cells were
counted and assayed in the Oroboros O2K.
Endogenous Immunoprecipitation. Endogenous immunoprecipitation of SOD1 was
performed using the Dynabeads Co-Immunoprecipitation Kit purchased from Thermo Fisher
Scientific (14321D) according to the manufacturer’s recommendations. To pull down SOD1, 7.5
mg of magnetic epoxy beads were conjugated to 37.5 μL of SOD1 antibody, per sample. As an
IgG control for SOD1 immunoprecipitation, primary anti-Chk1 was conjugated to magnetic beads.
Mitochondrial Enrichment. All mitochondrial isolations were done with the
Mitochondria Isolation Kit for Cultured Cells, obtained from Thermo Scientific (89874).
Mitochondrial pellets were isolated according to manufacturer’s protocol.
D2O labeling for protein turnover-rate determination. T-REx 293 cells were seeded
into 10 cm plates to 20% confluence and tetracycline was added to appropriate plates. At 40%
confluence, time-zero samples were imaged, harvested, and cryo-frozen. For the remaining
samples, cell culture media on all plates was replaced with DMEM complete medium containing
5% deuterium oxide. In addition, liquid in the 5% CO2 incubator water bath was replaced with 1
L of water containing 5% deuterium oxide to maintain D2O at a 5% equilibrium in the cell culture
medium. Over the next 24 hours, samples were imaged, harvested and cryo-frozen at designated
8, 16, and 24hr time points. One milliliter of cell labeled cell culture medium from each sample
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and from the incubator water bath was saved to affirm constant 5% D2O throughout the labelling
period. Once all samples were harvested, cells were prepared for mass spectrometry analysis by
filter-aided in-solution digest, as previously described (108) but with several modifications.
Specifically, cells were lysed in 6 M guanidine-HCl (pH8.5) containing protease inhibitors. For
full lysis, cells were incubated in lysis buffer with rotation at 4 °C, followed by homogenization
by shaking on an MP FastPrep-24 (MPBio) with 3.0 and 1.3 mm stainless steel beads. Lysates
were cleared by centrifugation at 21,000 x g for 20 minutes at 4 °C. Protein concentration of each
sample was determined by a BCA assay, and 100 µg of each sample was transferred to a fresh
screw-cap tube. Samples were reduced with 5 mM DTT for 5 minutes at 55 °C. Samples were
cooled to room temp and then incubated in the dark overnight with 15 mM iodoacetamide. The
following day, samples were transferred to 10 kDa MWCO filters and centrifuged at 14,000 x g
for 30 minutes. Samples were washed and centrifuged twice with 100 µL 6 M guanidine (30minute centrifugation at 14,000 x g), followed by two washes with 25 mM ammonium bicarbonate.
After washing, filters were transferred to fresh collection tubes and 400 µL of 25 mM ammonium
bicarbonate was added to the top of each filter. Mass spec-grade trypsin was then added to the
solution above each filter at a 1:50 (w/w) ratio and samples were incubated with very gentle
shaking at 37 °C overnight. The following morning, samples were centrifuged at 14,000 x g for 30
minutes, filtrant was collected and transferred to mass spec vials, samples were dry-lyophilized by
vacuum centrifugation, and finally resuspended in mass spec buffer A (3% acetonitrile, 0.1%
formic acid) to a final concentration of 1 µg/µL.
Samples were run on an Agilent Technologies 6530 mass spectrometer with a Chip-Cube
source. Source used Agilent Technologies Polaris HR-Chip-3C18 as the column. Digested
samples were subjected to a 27-minute gradient from 100% Buffer A (96.9% water, 3%
53

Acetonitrile, 0.1% Formic Acid) to 70% Buffer B (96.9% Acetonitrile, 3% Water, 0.1% Formic
Acid), followed by a 5-minute wash with 95% Buffer B.
Data was analyzed using the SpectrumMill program from Agilent Technologies using the
sixth release of the 2016 “Reviewed” Uniprot Homo sapiens taxonomy. Files were extracted,
searched using trypsin as the protease with two missed cleavages allowed. Autovalidation was
performed by SpectrumMill and then a no enzyme search was performed to identify unusual
trypsin cuts. Both database searches were performed with a fixed modification of
carbamidomethylation of cysteine and variable modifications including oxidation of methionine
and pyroglutamic acid from N-terminal glutamine.
Data was prepared for quantification using a modification of the extractor module from
DeuteRater (109). This in-house program takes the scans identified with DeuteRater’s extractors,
removes peaks 4 or more MS1 scans away from the main chromatogram and fills in any missing
scans in the chromatogram. All the abundances from the first isotopic peak (no extra neutrons) to
the 4th isotopic peak (3 extra neutrons) are then summed together. The resulting data was analyzed
using InfernoRDN using the standard method (110). Heat map analysis was prepared through
Heatmapper (111) using the expression analysis tool, without any clustering analysis.
SOD1 Aggregation Assay. T-REx HEK 293 with WT, G93A, or G93A/K122E SOD1
cells were plated at 20% confluence in two 15 cm plates per sample. Tetracycline was added to
culture medium to induce expression of the SOD1 constructs, and cells were allowed to express
for 48 hours. Tetracycline-containing medium was replenished after 24 hours due to tetracycline
instability. Cells were washed twice with ice-cold PBS, removed from the plate with a cell scraper,
and cells from each set of two 15 cm plates were combined (i.e., cells from the two WT-SOD1
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plates were combined, etc.) to a total of three samples. Cells were lysed in 600 μL of TNTE
coimmunoprecipitation buffer containing protease inhibitors by gentle rotation at 4 °C for 25
minutes. Following incubation, cells were passaged 10 times through a 25-G needle. Lysates were
cleared by centrifugation at 21,000 x g for 10 minutes at 4 °C. Five-hundred microliters of lysate
were loaded onto a Superdex 200 10/300 GL size exclusion column and separated and eluted with
PBS on an AKTA-Pure FPLC system (GE Healthcare). Lysates were fractionated at a rate of 0.5
mL/min into 48 fractions. Fractions were resolved via SDS PAGE on a 15% gel and
immunostained for FLAG and endogenous SOD1.
Mitochondrial Membrane Potential Assay. Mitochondrial membrane potential in cells
(same cells as in the Cell Survival Assay, described above) was assayed with the JC-1
Mitochondrial Membrane Potential Assay Kit (Abcam 113850) based on an adaptation of the
manufacturer’s instructions. Specifically, for each sample, medium was collected and saved in a
12x75 mm polystyrene test tube. Cells were washed once with PBS, which was added to the
corresponding test tube. Following the wash, cells were trypsinized and cells were collected into
the same tube. Tubes were capped and centrifuged at 1000 x g for 5 minutes. The supernatant was
discarded and cells were resuspended in 1 mL of warm complete medium. 10 μL of 200 μM JC-1
in DMSO was then added to each sample. No stain was added to a separate sample, as a control.
After addition of stain, the samples were protected from light and incubated at 37 ºC for 20
minutes, followed by a single 2 mL wash with PBS. Cells were resuspended in 500 μL of PBS and
analyzed on an Accuri C6 flow cytometer. Emission spectra from excitation at 488 nm were
detected with the FL-1 and FL-2 emission filters. Standard compensation was carried out based on
control Cas9 cells.
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Mitochondrial ROS Determination. The relative number of ROS-containing cells (same
cells as in the Cell Survival Assay) was determined by a flow cytometry-based application of
MitoSOX Red Mitochondrial Superoxide Indicator (Life Technologies M36008). After cells were
grown to 80% confluence in 12-well plates, 10 mM antimycin A was added to the positive control
cells to a final concentration of 30 µM and incubated for 40 minutes in a 5% CO2, 37 ºC incubator.
Following incubation, cell medium was collected and saved in a 12x75 mm polystyrene test tube.
Cells were washed once with PBS, which was added to the corresponding test tube. Following the
wash, cells were trypsinized and cells were collected into the same tube. Tubes were capped and
centrifuged at 600 x g for 3 minutes. The supernatant was discarded and cells were washed once
in 1 mL of warm complete medium. To stain cells, 5 mM MitoSOX Red was prepared in DMSO
as indicated by the manufacturer, which was then diluted to 5 μM in complete medium. All samples
were resuspended in 1 mL of the 5 μM MitoSOX-containing medium, except the negative control
which was resuspended in 1 mL of complete medium. After addition of stain, the samples were
protected from light and incubated for 10 minutes at 37 ºC and 5% CO2, followed by a 3-minute
centrifugation at 600 x g and a single 1 mL PBS wash. Cells were resuspended in 1 mL of PBS
and passed through a 70 μm cell strainer, diluted to approximately 500,000 cells/mL, and analyzed
on either an Accuri C6 or an Attune Acoustic Focusing Cytometer (Life Technologies). Emission
spectra from excitation at 488 nm were detected with the BL-3 or FL-3 emission filter.
Live Cell Confocal Imaging. Cells (same as in the Cell Survival Assay) were seeded at
medium density into 35 mm glass bottom microwell dishes (MatTek, P35GC-1.5-10-C) and
allowed to adhere for 24 hours. Prior to staining, positive control cells were treated for 40 minutes
with 30 µM antimycin A. To stain cells, MitoSOX Red was prepared as in the ROS determination
assay, cells were washed once with warm complete medium, and 1 mL of MitoSOX medium was
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added to each plate, except the negative control (1 mL complete medium). Cells were incubated
protected from light for 10 minutes at 37 ºC and 5% CO2 atmosphere, after which they were washed
3 x with warm complete medium. Nuclei were counterstained with 1 µg/mL Hoechst 33342 (Pierce
62249) according to manufacturer’s protocol, using a 10-minute incubation time, followed by a
PBS wash. Cells were then treated for at least 45 minutes with 1 mL of ProLong Live Antifade
Reagent, for live cell imaging (Molecular Probes P36975), 1:100 in complete DMEM. Finally, at
the time of imaging the plate was transferred to a humidified, 5% CO2, 37 ºC mini chamber adapted
to the microscope stage.
Cells were imaged on a Leica (Buffalo Grove, IL, USA) TCS SP8 HyD using the resonance
scanning mode. Images were collected from a 63x oil objective. Data collection parameters were
determined based on fluorescence signal from the positive control. Images were oversampled and
deconvolved with the Huygens Essential software version 16.10 (Scientific Volume Imaging, The
Netherlands, http://svi.nl) after which strong automatic dye separation was applied. All samples
and images were treated identically.
Statistical Analysis. Statistical analysis was conducted with either a one-way ANOVA
with Tukey’s post-hoc test or with an unpaired, equal variance, two-tailed t-test. Where indicated,
SEM was determined after normalization of each replicate.
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